References
- Matthews WB. Practical Neurology. 2nd. Blackwell: GB; 1970.
- Talbot K, Marsden R. Motor Neuron Disease: The Facts. Oxford University Press: Oxford, UK; 2008.
- Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994–1003.
- Goldstein L. Control of symptoms: cognitive dysfunction. Oliver D, Borasio GD, Walsh D. Palliative care in amyotrophic lateral sclerosis from diagnosis to bereavement. 2nd. Oxford University Press: Oxford, UK; 2006.
- Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein L, . Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
- Sloan R, Pongratz DE, Borasio GD. Communication: breaking the news. Oliver D, Borasio GD, Walsh D. Palliative Care in Amyotrophic Lateral Sclerosis – from diagnosis to bereavement. 2nd. Oxford University Press, Oxford; 2006.
- Heffernan C, Jenkinson C, Holmes T, Feder G, Kupfer R, Leigh PN, . Nutritional management in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:72–83.
- Miller RG, Jackson CE, Karsarkis EJ, England JD, Forshew D, Johnston W, . Practice parameter update. The care of the patient with amyotrophic lateral sclerosis: drug, nutritional and respiratory therapies (an evidence based review). Neurology. 2009;73;1218–26.
- Heffernen C, Jenkinson C, Holmes T, Macleod H, Kinnear W, Oliver D, . Management of respiration in MND/ALS patients: an evidence based review. Amyotroph Lateral Scler. 2006;7:5–15.
- Bourke SC, Tomlinson M, Willims L, Bullock RE, Shaw PJ, Gibson GJ. (2006) Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol. 2006;5:140–7.
- Hayashi H, Oppenheimer EA. ALS patients on TPPV: totally locked-in state: neurological findings and ethical implications. Neurology. 2003;61:135–7.
- Talbot K, Turner MR, Marsden R, Botell RE. Motor Neuron Disease: A Practical Manual. Oxford University Press; Oxford, UK; 2010.
- Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, ., and the ALS Practice Parameters Task Force: Practice Parameter. The care of the patient with amyotrophic lateral sclerosis (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52:1311–23.
- Agar M, Currow DC, Shelby-James TM, Plummer J, Sanderson C, Abernethy AP. Preference for place of care and place of death in palliative care: are these different questions? Pall Med. 2008;22:787–95.
- Oliver D. The quality of care and symptom control: the effects on the terminal phase of MND/ALS. J Neuro Sci. 1996;139(Suppl):134–6.
- Veldink JH, Wokke JHJ, van der Wal G, Vianney de Jong JMB, van den Berg LH. Euthanasia and physician assisted suicide among patients with amyotrophic lateral sclerosis in the Netherlands. N Eng J Med. 2002;346:1638–44.
- Campbell D. Suicide clinic challenged over patients who could have lived ‘ for decades ’ . The Guardian. 21.6.10.
- Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001:248:612–6.
- Ganzini L, Johnston WS, McFarland BH, Tolle SW, Lee MA. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med. 1998;339:967–73.
- Showalter SE. Compassion Fatigue. What Is It? Why Does It Matter? Recognizing the Symptoms, Acknowledging the Impact, Developing the Tools to Prevent Compassion Fatigue, and Strengthen the Professional Already Suffering From the Effects. Am J Hosp Palliat Care. 2010 – online 14.1.10.